"Some themes that can be gleaned from 2013’s warning letters are part of a constant drumbeat. Firms are cited by FDA for basic GMP violations and for making non-compliant disease claims on their products. But other themes, while perhaps not new per se, have acquired a renewed emphasis in the last year, Prochnow said, including the following:" . . .
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Exemptee Institute
The Designated Representative Institute
The Health, Drug, Prescription, and GMP Supersite Gift Store
Posts
No comments:
Post a Comment